13 investors back Mumbai healthtech startups in 2026. Mumbai is India's pharma and hospital capital. HealthQuad, Quadria, and W Health back the sector here.
Mumbai is the home of Indian pharma and hospitals. It hosts Cipla, Sun Pharma, and Lupin too.
These funds back pharma, hospitals, and health tech. They wait years for trials and approvals.
Healthtech rounds turn on data, IP, and proof. Ellty tracks every file open when you share your deck.
This guide lists 13 active Mumbai healthtech investors below.
| Type | Check size | Sector focus | Website | |
|---|---|---|---|---|
| HealthQuad | Healthcare-focused VC | US$5M-$25M | Digital health, diagnostics, pharma tech | healthquad.in |
| Quadria Capital | Healthcare PE | US$50M-$150M | Hospitals, pharma, diagnostics | quadriacapital.com |
| W Health Ventures | Healthtech VC | US$4M-$6M | Digital health, single-specialty care | whealthventures.com |
| Somerset Indus Capital | Healthcare PE | US$10M-$25M | Pharma, devices, diagnostics, delivery | somersetinduscap.com |
| Kotak Life Sciences Fund | Life-sciences PE | US$10M-$20M | Pharma, biotech, devices, diagnostics | kotakalternateasset.com |
| InvAscent | Life-sciences PE | US$10M-$30M | Pharma, healthcare delivery, devices | invascent.com |
| Eight Roads Ventures | Multi-stage VC | Up to US$40M | Healthtech, life sciences, digital health | eightroads.com |
| Lightrock India | Impact VC/PE | US$10M-$50M | Healthcare delivery, digital health | lightrock.com |
| Sixth Sense Ventures | Consumer VC | US$5M-$8M | Consumer health, wellness | sixthsenseventures.in |
| Elevation Capital | Early-stage VC | US$7M-$25M | Healthtech, life sciences, medtech | elevationcapital.com |
| 3one4 Capital | Early-stage VC | US$1M-$10M | Healthtech, AI, consumer, fintech | 3one4capital.com |
| Accel India | Early-stage VC | US$1M-$15M | Healthtech, consumer, SaaS | accel.com |
| Endiya Partners | Deep-tech / medtech VC | US$1M-$5M | Life sciences, medtech, AI diagnostics | endiya.com |
Run your Mumbai healthtech raise tight
Health funds dig into your outcomes and trials fast. Ellty logs every view in your data room.
Start free 14-day trialWhat a Mumbai healthtech investor backs
A Mumbai healthtech investor backs two kinds. Some fund startups, others fund hospitals.
VCs back digital health; PE funds back delivery. Pitching Maharashtra investors feels much the same.
They study your outcomes, IP, and unit economics. Most run a formal venture capital review process.
Ellty gives each fund one trackable link to your data room. You see who studied your deck before the first call.
Asia has more diabetes, cancer, and cardiovascular patients than anywhere else in the world.
13 Mumbai healthtech investors
1. HealthQuad
HealthQuad is India's largest healthcare-focused VC.
Recent Activity: Launched a Fund III targeting up to US$300M in 2025
LinkedIn: HealthQuad LinkedIn
Sector Focus: Digital health, diagnostics, pharma tech
Stage Focus: Early growth, Series A-C
Check Size: US$5M-$25M
Location: Gurugram / Mumbai-active
Website: healthquad.in
2. Quadria Capital
Quadria is Asia's largest healthcare-focused PE firm.
Recent Activity: Closed an oversubscribed ~US$1.07B Fund III in 2025
LinkedIn: Quadria Capital LinkedIn
Sector Focus: Hospitals, pharma, diagnostics
Stage Focus: Healthcare PE, growth
Check Size: US$50M-$150M
Location: Singapore / Mumbai-active
Website: quadriacapital.com
3. W Health Ventures
W Health is a Mumbai healthtech company-creation VC.
Recent Activity: Launched a US$70M Fund II and built Everhope Oncology
LinkedIn: W Health Ventures LinkedIn
Sector Focus: Digital health, single-specialty care
Stage Focus: Seed, early stage
Check Size: US$4M-$6M
Location: Mumbai
Website: whealthventures.com
4. Somerset Indus Capital
Somerset Indus is a Mumbai healthcare-focused PE fund.
Recent Activity: Neared a ~US$250M final close for its third health fund
LinkedIn: Not listed
Sector Focus: Pharma, devices, diagnostics, delivery
Stage Focus: Healthcare PE, growth
Check Size: US$10M-$25M
Location: Mumbai
Website: somersetinduscap.com
5. Kotak Life Sciences Fund
Kotak runs a Mumbai life-sciences PE fund.
Recent Activity: First close at Rs 250 Cr and backed ZeroHarm Sciences
LinkedIn: Not listed
Sector Focus: Pharma, biotech, devices, diagnostics
Stage Focus: Early to growth
Check Size: US$10M-$20M
Location: Mumbai
Website: kotakalternateasset.com
6. InvAscent
InvAscent is India's leading life-sciences PE firm.
Recent Activity: Invested Rs 140 Cr in Mumbai's SRV Hospitals in 2025
LinkedIn: Not listed
Sector Focus: Pharma, healthcare delivery, devices
Stage Focus: Healthcare PE, growth
Check Size: US$10M-$30M
Location: Mumbai / Bengaluru
Website: invascent.com
Share your deck and track every health fund
Ellty shows when HealthQuad or Quadria opens your deck. Follow up with each fund at the right time.
Start free 14-day trial7. Eight Roads Ventures
Eight Roads is a Mumbai VC with a dedicated health fund.
Recent Activity: Runs a US$250M healthtech and life-sciences fund
LinkedIn: Eight Roads LinkedIn
Sector Focus: Healthtech, life sciences, digital health
Stage Focus: Early to growth
Check Size: Up to US$40M
Location: Mumbai
Website: eightroads.com
8. Lightrock India
Lightrock is a global impact VC with a Mumbai office.
Recent Activity: Opened a second India office in Mumbai and backs Kauvery
LinkedIn: Lightrock LinkedIn
Sector Focus: Healthcare delivery, digital health
Stage Focus: Growth
Check Size: US$10M-$50M
Location: London / Mumbai
Website: lightrock.com
9. Sixth Sense Ventures
Sixth Sense is a Mumbai consumer VC active in health.
Recent Activity: An active India consumer-health and wellness investor
LinkedIn: Sixth Sense Ventures LinkedIn
Sector Focus: Consumer health, wellness
Stage Focus: Seed, Series A
Check Size: US$5M-$8M
Location: Mumbai
Website: sixthsenseventures.in
10. Elevation Capital
Elevation is an early-stage India VC with a health thesis.
Recent Activity: Launched a US$400M fund targeting healthtech and medtech
LinkedIn: Elevation Capital LinkedIn
Sector Focus: Healthtech, life sciences, medtech
Stage Focus: Seed, Series A
Check Size: US$7M-$25M
Location: Gurugram / Bengaluru
Website: elevationcapital.com
11. 3one4 Capital
3one4 is an India VC active in healthtech and AI.
Recent Activity: Held a US$175M first close of Fund V backing healthtech
LinkedIn: 3one4 Capital LinkedIn
Sector Focus: Healthtech, AI, consumer, fintech
Stage Focus: Seed, Series A
Check Size: US$1M-$10M
Location: Bengaluru
Website: 3one4capital.com
12. Accel India
Accel is a top India VC with healthtech across its book.
Recent Activity: An active India healthtech and digital-health investor
LinkedIn: Accel LinkedIn
Sector Focus: Healthtech, consumer, SaaS
Stage Focus: Seed, Series A
Check Size: US$1M-$15M
Location: Bengaluru
Website: accel.com
13. Endiya Partners
Endiya is a deep-tech VC focused on health and medtech.
Recent Activity: Closed Fund III backed by IFC and AIIB
LinkedIn: Endiya Partners LinkedIn
Sector Focus: Life sciences, medtech, AI diagnostics
Stage Focus: Seed, Series A
Check Size: US$1M-$5M
Location: Hyderabad
Website: endiya.com
Pharma, hospitals, and diagnostics
Pharma, hospitals, and diagnostics draw capital. Mumbai anchors all of India's pharma base.
Funds want real outcomes and clean compliance. A weak data story rarely raises a big round.
Patient and trial data is highly sensitive here. Set granular permissions on each file you share.
Ellty controls who can open each clinical file. You see exactly who studied your data and when.
Trials, IP, and regulation
Healthtech lives or dies by trials and approvals. One data gap can stall your whole round fast.
Funds probe your trial design and approvals. Read through our due diligence timeline guide first.
Trial and approval docs are sensitive to share. Lock them all down with strong security controls.
Ellty gates each file and logs every single view. Each fund gets a link you can track and revoke.
From seed to growth in healthtech
Mumbai holds funds for nearly every health stage. W Health and HealthQuad back early rounds.
Each stage wants a bigger and harder proof point. Run a clean due diligence process right from day one.
Know the gap between hard and soft due diligence. It shapes what each fund will end up asking for.
Ellty logs who opened each file and exactly when. You can follow up at the right moment every time.
How to pitch a Mumbai healthtech investor
Lead with outcomes, clinical proof, and economics.
- 1.Lead with outcomes and clinical proof.Health funds back data over a demo.
- 2.Show clear approvals and unit economics.Weak proof stalls health rounds fast.
- 3.Share one Ellty link to your data room.Track who opens it and which files.
- 4.Follow up the moment a fund digs in.Ellty tells you exactly when they do.
How Ellty helps you land a healthtech investor in Mumbai
You've shortlisted your Mumbai healthtech investors already. Set up a data room before the first call.
- 1.Upload your outcomes, trials, and deck.Set access per fund or per partner.
- 2.Share one trackable link with each fund.Each fund gets its own tracked link.
- 3.Watch opens and follow up at the right time.Use Ellty analytics to time each nudge.
Mumbai healthtech investor questions
- HealthQuad and W Health back early teams. Quadria backs hospitals and pharma too.
- Cheques run US$1M to US$150M in 2026 here. PE funds write the biggest cheques.
- Real clinical proof and clean outcomes. Strong unit economics also matter a lot.
- It is India's pharma and hospital capital. Cipla and Sun Pharma are based here.
- Yes, PE funds like Quadria back hospitals. They fund large healthcare delivery.
- Before your very first investor call. Track who opens your deck and metrics.
